192369-93-0 Usage
Uses
Used in Organic Synthesis:
5-(Bromomethyl)-1H-indazole hydrobromide is used as a synthetic intermediate for the preparation of various organic compounds. Its bromomethyl group allows for further functionalization and modification of the molecule, making it a versatile building block in organic chemistry.
Used in Pharmaceutical Research:
5-(Bromomethyl)-1H-indazole hydrobromide is used as a research compound in the development of new pharmaceuticals. Its indazole core and bromomethyl group provide a unique structure that can be optimized for specific biological targets, such as enzymes or receptors, to treat various diseases.
Used in Anticancer Applications:
5-(Bromomethyl)-1H-indazole hydrobromide is used as a potential anticancer agent due to the biological activities of indazoles and their derivatives. It may exhibit inhibitory effects on tumor growth and progression by targeting specific cancer-related pathways or mechanisms.
Used in Antiviral Applications:
5-(Bromomethyl)-1H-indazole hydrobromide is used as a potential antiviral agent, as some indazole derivatives have shown antiviral properties. It may interfere with viral replication or assembly, providing a potential therapeutic option against viral infections.
Used in Antibacterial Applications:
5-(Bromomethyl)-1H-indazole hydrobromide is used as a potential antibacterial agent, as certain indazole derivatives have demonstrated antibacterial activity. It may target specific bacterial processes or enzymes, contributing to the development of new antibiotics to combat bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 192369-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,3,6 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 192369-93:
(8*1)+(7*9)+(6*2)+(5*3)+(4*6)+(3*9)+(2*9)+(1*3)=170
170 % 10 = 0
So 192369-93-0 is a valid CAS Registry Number.
192369-93-0Relevant academic research and scientific papers
Non-covalent thrombin inhibitors
-
, (2008/06/13)
The present invention provides compounds which have a pyrazinone or pyridinone ring at P3 and which feature a six member heterocyclic ring having two ring nitrogen atoms and the remainder of the ring atoms carbon atoms at P1. These compounds have biologic
Substituted hydrazinyl heteroaromatic inhibitors of thrombin
-
, (2008/06/13)
Compounds of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: as described herein.
Thrombin inhibitors having a lactam at P3
-
, (2008/06/13)
The present invention provides compounds having a lactam ring at P3 and at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms. These compounds have biological activity as active and potent inhibitors of thrombin. Their pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds and pharmaceutical compositions comprising these compounds as therapeutic agents for treatment of disease states in mammals which are characterized by abnormal thrombosis are also described.
